Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation

Human Molecular Genetics

Volumn 12, Issue 4, 2003, Pages 423-433

  Funke Kaiser, Heiko ^a   Reichenberger, Florian ^a   Köpke, Karla ^b   Herrmann, Stefan Martin ^a,c   Pfeifer, Jacqueline ^a   Orzechowski, Hans Dieter ^a   Zidek, Walter ^a   Paul, Martin ^a   Brand, Eva ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENDOTHELIN; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME 1B; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; BINDING AFFINITY; BLOOD PRESSURE REGULATION; CELL CYCLE; CONTROLLED STUDY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE IDENTIFICATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; REVIEW; WILD TYPE;

ADULT; AGED; ALLELES; ASPARTIC ENDOPEPTIDASES; BLOOD PRESSURE; CELLS, CULTURED; CLONING, MOLECULAR; DNA; E2F2 TRANSCRIPTION FACTOR; FEMALE; GENES, REPORTER; GENOTYPE; HAPLOTYPES; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0037440673     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg040     Document Type: Review

References (61)

1. Ward, R. (1990) Familial aggregation and genetic epidemiology of blood pressure. In Laragh, J.H. and Brenner, B.M. (eds), Hypertension: Pathophysiology, Diagnosis, and Management. Raven Press, New York, pp. 81-100.
2. Lander, E.S. and Schork, N.J. (1994) Genetic dissection of complex traits. Science, 265, 2037-2048.
3. Xu, D. and Yanagisawa, M. (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell, 78, 473-485.
4. Emoto, N. and Yanagisawa, M. (1995) Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J. Biol. Chem., 270, 15262-15268.
5. Korth, P., Bohle, R.M., Corvol, P. and Pinet, F. (1999) Cellular distribution of endothelin-converting enzyme-1 in human tissues. J. Histochem. Cytochem., 47, 447-461.
6. Yanagisawa, H., Yanagisawa, M., Kapur, R.P, Richardson, J.A., Williams, S.C., Clouthier, D.E., de Wit, D., Emoto, N. and Hammer, R.E. (1998) Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development, 125, 825-836.
7. Ihling, C., Szombathy, T., Bohrmann, B., Brockhaus, M., Schaefer, H.E. and Loeffler, B.M. (2001) Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation, 104, 864-869.
8. Serneri, G.G., Cecioni, I., Vanni, S., Paniccia, R., Bandinelli, B., Vetere, A., Janming, X., Bertolozzi, I., Boddi, M., Lisi, G.F. et al. (2000) Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy. Circ. Res., 86, 377-385.
9. Shimada, K., Matsushita, Y., Wakabayashi, K., Takahashi, M., Matsubara, A., Iijima, Y. and Tanzawa, K. (1995) Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem. Biophys. Res. Commun., 207, 807-812.
10. Schmidt, M., Kroger, B., Jacob, E., Seulberger, H., Subkowski, T., Otter, R., Meyer, T., Schmalzing, G. and Hillen, H. (1994) Molecular characterization of human and bovine ECE-1. FEBS Lett., 356, 238-243.
11. Schweizer, A., Valdenaire, O., Nelbock, P., Deuschle, U., Dumas Milne Edwards, J.B., Stumpf, J.G. and Loffler, BM. (1997) Human ECE-1: three isoforms with distinct subcellular localizations. Biochem. J., 328, 871-877.
12. Valdenaire, O., Lepailleur-Enouf, D., Egidy, G., Thouard, A., Barret, A., Vranckx, R., Tougard, C. and Michel, J.B. (1999) A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter. Eur. J. Biochem., 264, 341-349.
13. Orzechowski, H.D., Richter, C.M., Funke-Kaiser, H., Kroger, B., Schmidt, M., Menzel, S., Bohnemeier, H. and Paul, M. (1997) Evidence of alternative promoters directing isoform-specific expression of human endothelin-converting enzyme-1 mRNA in cultured endothelial cells. J. Mol. Med., 75, 512-521.
14. Funke-Kaiser, H., Bolbrinker, J., Theis, S., Lemmer, J., Richter, C.M., Paul, M. and Orzechowski, H.D. (2000) Characterization of the c-specific promoter of the gene encoding human endothelin-converting enzyme-1 (ECE-1). FEBS Lett., 466, 310-316.
15. Valdenaire, O., Rohrbacher, E. and Mattei, M.G. (1995) Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J. Biol. Chem., 270, 29794-29798.
16. Albertin, G., Rossi, G.P., Majone, F., Tiso, N., Mattara, A., Danieli, G.A., Pessina, A.C. and Palu, G. (1996) Fine mapping of the human endothelin-converting enzyme gene by fluorescent in situ hybridization and radiation hybrids. Biochem. Biophys. Res. Commun., 221, 682-687.
17. Verdecchia, P., Clement, D., Fagard, R., Palatini, P. and Parati, G. (1999) Blood pressure monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press. Monit., 4, 303-317.
18. Heinemeyer, T., Chen, X., Karas, H., Kel, A.E., Kel, O.V., Liebich, I., Meinhardt, T., Reuter, I., Schacherer, F. and Wingender, E. (1999) Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. Nucl. Acids Res., 27, 318-322.
19. Tiret, L., Poirier, O., Nicaud, V., Barbaux, S., Herrmann, S.M., Perret, C., Raoux, S., Francomme, C., Lebard, G., Tregouet, D. and Cambien, F. (2002) Heterogeneity of linkage disequilibrium in human genes has implications for association studies of common diseases. Hum. Mol. Genet., 11, 419-429.
20. Cambien, F., Poirier, O., Nicaud, V., Herrmann, S.M., Mallet, C., Ricard, S., Behague, I., Hallet, V., Blanc, H., Loukaci, V. et al. (1999) Sequence diversity in 36 candidate genes for cardiovascular disorders. Am. J. Hum. Genet., 65, 183-191.
21. Radin, M.J., Holycross, B.J., Sharkey, L.C., Shiry, L. and McCune, S.A. (2002) Gender modulates activation of renin-angiotensin and endothelin systems in hypertension and heart failure. J. Appl. Physiol., 92, 935-940.
22. Dubey, R.K., Jackson, E.K., Keller, P.J., Imthurn, B. and Rosseli, M. (2001) Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension, 37, 640-644.
23. Webb, C.M., Ghatei, M.A., McNeill, J.G. and Collins, P. (2000) 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation, 102, 1617-1622.
24. Webb, D.J. (1995) Endogenous endothelin generation maintains vascular tone in humans. J. Hum. Hypertens., 9, 459-463.
25. Polderman, K.H., Stehouwer, C.D., van Kamp, G.J., Dekker, G.A., Verheugt, F.W. and Gooren, L.J. (1993) Influence of sex hormones on plasma endothelin levels. Ann. Intern. Med., 118, 429-432.
26. Benigni, A. and Remuzzi, G. (1999) Endothelin antagonists. Lancet, 353, 133-138.
27. Pinto-Sietsma, S.J. and Paul, M. (1998) A role for endothelin in the pathogenesis of hypertension: Fact or fiction? Kidney Int., 54(Suppl. 67), 115-121.
28. Vanni, S., Polidori, G., Cecioni, I., Serni, S., Carini, M. and Modesti, P.A. (2002) ET(B) receptor in renal medulla is enhanced by local sodium during low salt intake. Hypertension, 40, 179-185.
29. Gariepy, C.E., Ohuchi, T., Williams, S.C., Richardson, J.A. and Yanagisawa, M. (2000) Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J. Clin. Invest., 105, 925-933.
30. Gilmore, E.S., Stutts, M.J. and Milgram, S.L. (2001) SRC family kinases mediate epithelial Na+ channel inhibition by endothelin. J. Biol. Chem., 276, 42610-42617.
31. Lazurova, I., Wagnerova, H., Trejbal, D., Olexa, P., Ondic, O., Petrovicova, J., Kovacova, A. and Mitro, P. (1999) A study of the renal sodium excretion during the normal menstrual cycle using method of passive leg rising. Exp. Clin. Endocrinol. Diabetes, 107, 198-202.
32. Bisson, D.L., Dunster, G.D., O'Hare, J.P., Hampton, D. and Penney, M.D. (1992) Renal sodium retention does not occur during the luteal phase of the menstrual cycle in normal women. Br. J. Obstet. Gynaecol., 99, 247-252.
33. Levy, N., Gordin, M., Mamluk, R., Yanagisawa, M., Smith, M.F., Hampton, J.H. and Meidan, R. (2001) Distinct cellular localization and regulation of endothelin-1 and endothelin-converting enzyme-1 expression in the bovine corpus luteum: implications for luteolysis. Endocrinology, 142, 5254-5260.
34. Grubbs, A.L., Anstadt, M.P. and Ergul, A. (2002) Saphenous vein endothelin system expression and activity in African American patients. Arterioscler Thromb. Vasc. Biol., 22, 1122-1127.
35. Miyauchi, T. and Masaki, T. (1999) Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol., 61, 391-415.
36. Charron, F. and Nemer, M. (1999) GATA transcription factors and cardiac development. Semin. Cell Dev. Biol., 10, 85-91.
37. Simon, M.C. (1995) Gotta have GATA. Nat. Genet., 11, 9-11.
38. Lee, M.-E., Temizer, D.H., Clifford, J.A. and Quertermous, T. (1991) Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells. J. Biol. Chem., 266, 16188-16192.
39. Trimarchi, J.M. and Lees, J.A. (2002) Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol., 3, 11-20.
40. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G. Jr, Livingston, D.M., Orkin, S.H. and Greenberg, M.E. (1996) E2F-1 functions in mice to promote apoptosis and suppresses proliferation. Cell, 85, 549-561.
41. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E. and Dyson, N.J. (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85, 537-548.
42. Weinberg, R.A. (1996) E2F and cell proliferation: a world turned upside down. Cell, 85, 457-459.
43. Fueyo, J., Gomez-Manzano, C., Yung, W.K., Liu, T.J., Alemany, R., McDonnell, T.J., Shi, X., Rao, J.S., Levin, V.A. and Kyritsis, A.P. (1998) Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat. Med., 4, 685-690.
44. Parr, M.J., Manome, Y., Tanaka, T., Wen, P., Kufe, D.W., Kaelin, W.G. Jr and Fine, H.A. (1997) Tumor-selective transgene expression in vivo mediated by an E2F-responsive adenoviral vector. Nat. Med., 3, 1145-1147.
45. Spyridopoulos, I., Principe, N., Krasinski, K.L., Xu, S., Kearney, M., Magner, M., Isner, J.M. and Losordo, D.W. (1998) Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Circulation, 98, 2883-2890.
46. Morishita, R., Gibbons, G.H., Horiuchi, M., Ellison, K.E., Nakama, M., Zhang, L., Kaneda, Y., Ogihara, T. and Dzau, V.J. (1995) A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl Acad. Sci. USA, 92, 5855-5859.
47. Mann, M.J., Whittemore, A.D., Donaldson, M.C., Belkin, M., Conte, M.S., Polak, J.F., Orav, E.J., Ehsan, A., Dell'Acqua, G. and Dzau, V.J. (1999) Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. Lancet, 354, 1493-1498.
48. Diep, Q.N., El Mabrouk, M., Cohn, J.S., Endemann, D., Amiri, F., Virdis, A., Neves, M.F. and Schiffrin, E.L. (2002) Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation, 105, 2296-2302.
49. Diep, Q.N., El Mabrouk, M., Touyz, R.M. and Schiffrin, E.L. (2001) Expression of cell cycle proteins in blood vessels of angiotensin II-infused rats. Hypertension, 37, 604-608.
50. Hadrava, V., Tremblay, J., Sekaly, R.P. and Hamet, P. (1992) Accelerated entry of aortic smooth muscle cells from spontaneously hypertensive rats into the S phase of the cell cycle. Biochem. Cell. Biol., 70, 599-604.
51. Hamada, M., Nishio, I., Baba, A., Fukuda, K., Takeda, J., Ura, M., Hano, T., Kuchii, M. and Masuyama, Y. (1990) Enhanced DNA synthesis of cultured vascular smooth muscle cells from spontaneously hypertensive rats. Atherosclerosis, 81, 191-198.
52. Sluck, J.M., Lin, R.C., Katolik, L.I., Jeng, A.Y. and Lehmann, J.C. (1999) Endothelin converting enzyme-1-, endothelin-1-, and endothelin-3-like immunoreactivity in the rat brain. Neuroscience, 91, 1483-1497.
53. Eckman, E.A., Reed, D.K. and Eckman, C.B. (2001) Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme. J. Biol. Chem., 276, 24540-24548.
54. Marcadet, A., O'Connell, P. and Cohen, D. (1986) Standardized southern blot workshop technique. In Dupont, B. (ed.), Histocompatibility Testing. Springer, New York, Vol. 1, pp. 553-560.
55. Herrmann, S.M., Funke-Kaiser, H., Schmidt-Petersen, K., Nicaud, V., Gautier-Bertrand, M., Evans, A., Kee, F., Arveiler, D., Morrison, C., Orzechowski, H.D. et al. (2001) Characterization of polymorphic structure of cathepsin G gene: role in cardiovascular and cerebrovascular diseases. Arterioscler. Thromb. Vasc. Biol., 21, 1538-1543.
56. Saiki, R.K., Bugawan, T.L., Horn, G.T., Mullis, K.B. and Erlich, H.A. (1986) Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature, 324, 163-166.
57. Herrmann, S.M., Ricard, S., Nicaud, V., Mallet, C., Evans, A., Ruidavets, J.B., Arveiler, D., Luc, G. and Cambien, F. (1998) The P-selectin gene is highly polymorphic: reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum. Mol. Genet., 7, 1277-1284.
58. Lynch, M. and Walsh, B. (1998) Genetics and Analysis of Quantitative Traits. Sinauer, Sunderland, pp. 60-61.
59. Garnier-Gere, P. and Dillmann, C. (1992) A computer program for testing pairwise linkage disequilibria in subdivided populations. J. Hered., 83, 239.
60. Rohde, K. and Fuerst, R. (2001) Haplotyping and estimation of haplotype frequencies for closely linked biallelic multilocus genetic phenotypes including nuclear family information. Hum. Mutat., 17, 289-295.
61. Schreiber, E., Matthias, P., Müller, M.M. and Schaffner W. (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucl. Acids Res., 17, 6419.